Back to search results

A Study to Assess the Incidence of Skin Cancers in Patients With Epidermolysis Bullosa Receiving Filsuvez

Abroad (travel likely)Recruiting

Conditions

Epidermolysis Bullosa, Dystrophic · Epidermolysis Bullosa, Junctional

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • CHU de Toulouse, Hôpital Larrey, Toulouse, France

    Contact: Study coordinator (Juliette Mazereeuw Hautier) · mazereeuw-hautier.j@chu-toulouse.fr · 33 5 67 77 18 76
    Contact: Principal Investigator (Juliette Mazereeuw Hautier)

  • Hospital of Skin and Venereal Diseases of Thessaloniki, Thessaloniki, Greece

    Contact: Study coordinator (Dimitra Kiritsi) · dimkyritsi@auth.gr · 0030-6983375771
    Contact: Principal Investigator (Dimitra Kiritsi)

  • Hospital Clinic, Barcelona, Barcelona, Spain

    Contact: Study coordinator (Josep Riera Monroig) · jriera@clinic.cat · 93 227 54 00
    Contact: Principal Investigator (Josep Riera Monroig)

  • Hospital San Juan de Dios (Barcelona), Barcelona, Spain

    Contact: Study coordinator (Asuncion Vicente) · asuncion.vicente@sjd.es
    Contact: Principal Investigator (Asuncion Vicente)

  • Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom

    Contact: Study coordinator (Jemima Mellerio) · jemima.mellerio@gstt.nhs.uk · 44 20 7188 6399
    Contact: Principal Investigator (Jemima Mellerio)
View source on ClinicalTrials.gov(opens in a new tab)